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Abstract
Background: Viral protein X (Vpx) of SIV has been reported to be important for establishing infection in vivo. Vpx
has several different activities in vitro, promoting preintegration complex import into the nucleus in quiescent
lymphocytes and overcoming a block in reverse transcription in macrophages. Vpx interacts with the DDB1-CUL4-
DCAF1 E3 ligase complex, which may or may not be required for the ascribed functions. The goal of the current
study was to determine whether these activities of Vpx are important in vivo.
Results: An infectious, pathogenic clone of SIVmne was used to examine correlations between Vpx functions in
vitro and in vivo. Three previously described HIV-2 Vpx mutants that were shown to be important for nuclear
import of the preintegration complex in quiescent lymphocytes were constructed in SIVmne: A vpx-deleted virus, a
truncation of Vpx at amino acid 102 that deletes the C-terminal proline-rich domain (X(102)), and a mutant with
tyrosines 66, 69, and 71 changed to alanine (X(y-a)). All mutant viruses replicated similarly to wild type SIVmne027
in primary pigtail macaque PBMCs, and were only slightly retarded in CEMx174 cells. However, all the vpx mutant
viruses were defective for replication in both human and pigtail monocyte-derived macrophages. PCR assays
demonstrated that the efficiency of reverse transcription and the levels of viral integration in macrophages were
substantially reduced for the vpx mutant viruses. In vitro, the X(y-a) mutant, but not the X(102) mutant lost
interaction with DCAF1. The wild type SIVmne027 and the three vpx mutant SIVs were inoculated by the intra-
rectal route into pigtail macaques. Peak levels of plasma viremia of the vpx mutant SIVs were variable, but
consistently lower than that observed in macaques infected with wild type SIVmne. In situ hybridization for SIV
demonstrated that compared to wild type SIVmne infected macaques five of the six animals inoculated with the
vpx mutant SIVs had only low levels of SIV-expressing cells in the rectum, most intestinal epithelial tissues, spleen,
and mesenteric and peripheral nodes.
Conclusions: This work demonstrates that the activities of Vpx to overcome restrictions in culture in vitro are also
likely to be important for establishment of infection in vivo and suggest that both the nuclear localization and
DCAF1-interaction functions of Vpx are critical in vivo.
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Background
The vpx and vpr genes of HIV-2 and SIVmac evolved
from a common ancestral gene product as a result of
non-homologous recombination [1-3]. Vpx is a protein
with 112 residues, that is predicted to have 3 alpha
helices and a proline-rich tail [4-7]. It is efficiently
packaged into virions [8]. Although Vpx is dispensable
for infection of proliferating cells, it is critical for infec-
tion of quiescent cells. Early studies established a role of
Vpx in the nuclear import of preintegration complexes
in quiescent cells [9,10]. The PIC nuclear import activity
is mediated by two distinct Vpx domains that include
tyrosine-rich sequences within residues 65-72 in the
third predicted alpha helix of Vpx and a proline-rich
domain in residues 102-112C-terminal to the predicted
alpha helical core of the protein [10-12]. Interactive
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proteins that promote Vpx nuclear import activity
include a-actinin, importins a and b, nucleoporins, and
heat shock protein 40 member DnaJB6 [13-16].
More recent studies demonstrate that Vpx promotes
reverse transcription in macrophages and dendritic cells
[17-19]. The activity in macrophages has been attributed
to Vpx binding to a ubiquitin ligase complex containing
cullin4a (CUL4), damaged DNA-binding protein 1
(DDB1), and the DDB1- and CUL4-associated factor 1
(DCAF1) [18-21]. Vpx residue Q76 and Vpx ubiquitina-
tion have been shown to be important for interaction
with DCAF1 [18-21]. The target of ubiquitination, that
restricts reverse transcription by this complex in the
absence of Vpx, has recently been ascribed to SAM-
domain HD-domain containing protein 1 (SAMHD1), a
product of an unconventional cell-intrinsic innate
immune response [22,23]. SAMHD1 appears to function
as a deoxynucleoside triphosphate triphosphohydrolase
[24,25]. It is unclear which of these distinct activities of
Vpx in quiescent cells is dominant, and whether these
activities are cell-type dependent.
Vpx has also been shown to be important for the abil-
ity of the acutely pathogenic variant of SIVsmm pbj to
establish infection in vivo [26]. After intrarectal inocula-
tion, both wild type and Vpx mutant SIVs were trans-
mitted across the rectal mucosa and detected by in situ
RNA hybridization and immunohistochemistry within 4
days of inoculation. More than ninety percent of cells
infected with either virus in the rectal mucosa were lym-
phocytes. Macrophages represented a minority of the
infected cell population. Local amplification of infection
and dissemination was observed with wild-type SIV, but
dissemination of SIVsmm pbj ΔVpx was retarded.
Slower dissemination of SIVsmm pbj ΔVpx compared
to wild type virus was also seen after intravenous inocu-
lation. In order to confirm and extend these findings,
the current study was carried out to investigate the in
vivo relevance of specific functions ascribed to Vpx in
vitro and in vivo using SIVmne virus, a less acutely
pathogenic and more AIDS-like model of HIV infection
than SIVsmm pbj [27].
Results
Characterization of SIVmne Vpx mutations
Previous studies of HIV-2rod Vpx demonstrated a criti-
cal role for nuclear localization of two domains encom-
passing a tyrosine-rich sequence within residues 65-72
and a proline-rich sequence within residues 101-112
(Figure 1) [10,11]. In order to determine the role of
these domains in vivo, mutations were introduced into a
pathogenic molecular clone, SIVmne027 [27-29]. Over-
all, SIVmne Vpx differs from HIV-2rod Vpx at 15
codons (13.4%), situated in the predicted 3rd a-helix
and N- and C-terminal to the helical protein core [7].
The first clone, SIVΔVpx, contained mutations that
eliminated the initiator methionine codon and intro-
duced a termination codon in place of residue 20 in
order to eliminate Vpx expression. The second mutant,
SIV-X(y-a), included substitutions of tyrosines 66, 69,
and 71 with alanines. The third mutant, SIV-X(102),
introduced two termination codons in place of proline
residues 103-104, resulting in a truncated protein that
deleted the poly-proline stretch at the C-terminus of the
protein. The expression and packaging of each Vpx
mutant protein was examined by immunoblotting (Fig-
ure 2 and Additional file 1: Figure S1). In previous stu-
dies of HIV-2rod, both mutants were expressed and
incorporated into virions [11]. With SIVmne027, lower
band intensities compared to wild type were seen with
the mutants, which could reflect differences in stability
or packaging.
The replication fitness of the SIVmne-derived molecu-
lar clones was assessed in both cell lines and primary
cells. First, virus replication was measured in CEMx174
cells (Figure 3). Cells were infected with equivalent
amounts of each virus, and virus production assessed in
culture supernatants by reverse transcriptase activity
measurements. All four viruses replicated to high levels,
although the mutant Vpx SIVs were slightly retarded in
their replication kinetics compared to wild-type
SIVmne027. Next, the replication of the mutant Vpx
SIVs was examined in primary human monocyte-derived
macrophages (MDMs), using 100-400 ng of each virus,
based on p27 antigen ELISA, and monitored by reverse
transcriptase activity measurements (Figure 4). Only
SIVmne027 gave rise to high levels of replication in
MDMs during the 24 days of culture, with average peak
levels of reverse transcriptase activity of 68,000, 58,000,
and 160,000 cpm/0.08 ml in cultures initiated with 100,
200, or 400 ng of virus, respectively. In contrast,
SIVΔVpx, SIV-X(y-a), and SIV-X(102) infection of
MDMs gave rise to average peak reverse transcriptase
levels < 42,000 cpm/0.08 ml at all dilutions.
Finally, the replication of the mutant Vpx SIVs was
examined in primary macaque peripheral blood mono-
nuclear cells (PBMCs) and MDMs (Figure 5).
SIVmne027 and each of the mutant SIV variants repli-
cated to similar levels in PBMCs (Figure 5A). Similar to
the experiments with human MDM, only SIVmne027
was capable of productive infection in macaque MDMs;
none of the mutant Vpx SIV viruses produced detect-
able levels of p27 Gag antigen in the MDM infections
(Figure 5B).
To determine if the failure of the Vpx mutants to
replicate in MDMs resulted from an inhibition of
reverse transcription, the early events of virus infection
were characterized by real time PCR analysis. Primary
human MDMs were infected with VSV-G pseudotyped
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SIVs in triplicate. Viral DNA was extracted at 24 and 48
h post-infection for PCR analysis (Figure 6). Consistent
with the finding that Vpx is required for efficient reverse
transcription in macrophages, both early and late viral
DNA products were substantially reduced in the mutant
Vpx SIV infected cells. At 24 and 48 h, the levels of
early reverse transcription products in cells infected
with mutant SIV viruses were reduced to 10-20% and
15-40%, respectively, of the levels seen in the cells
Figure 1 Sequence alignment of HIV-2rod and SIVmne Vpx. The amino acid sequence of HIV-2 strain ROD10/ES Vpx is provided with
differences present in SIVmne indicated, and dashes representing residues identical in both Vpx products. Tyrosine residues subjected to
mutation in SIV-X(y-a) are underlined, and their codon numbers are indicated above each residue. Pro residues 103-104 are underlined since
they were substituted with termination codons in SIV-X(102), with the C-terminal Gly residue in the predicted truncated protein indicated by the
number above the residue.
Figure 2 Expression and packaging of SIV Vpx mutant
molecular clones. SIV molecular clones lacking Vpx expression
were complemented in trans with indicated Vpx mutants and Vpx
WT by transient transfection of 293 T cells. MG132 was added 24 h
post-transfection. Supernatants were collected at 48 h and virions
were concentrated by ultracentrifugation through a 20% sucrose
cushion. Vpx and CA expression were analyzed by immunoblot.
Figure 3 Replication fitness of SIV Vpx mutant molecular
clones in CEMx174 cells. Wild type and Vpx mutant SIVs (50 ng by
p27 antigen ELISA) were used for infection, and reverse transcriptase
activity in solubilized released virus present in 0.08 ml of culture
supernatant was measured as cpm of [3H]-thymidine incorporation
into DNA at each indicated time point.
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infected with wild type SIVmne027 (Figure 6A). The
levels of late reverse transcription products (Figure 6B)
and integrated (Figure 6C) viral DNA sequences in
macrophages infected with mutant viruses were also
reduced to < 5% and < 10%, respectively, of the cells
infected with wild type SIVmne027. These findings are
consistent with the previously reported role of Vpx in
promoting reverse transcription in macrophages or pro-
moting the stability of the reverse transcriptase products
[18,19]. These findings also demonstrate that both the
triple tyrosine and C-terminal proline domains are
necessary for this function of Vpx.
Since the activity in macrophages has been attributed
to Vpx binding to a ubiquitin ligase complex containing
Figure 4 Replication of SIV Vpx mutant molecular clones in primary human macrophages. A) Wild type and B-D) Vpx mutant SIVs, in the
amounts indicated in the key and performed in duplicate experiments, were used to infect M-CSF-stimulated human monocyte-derived
macrophages, and reverse transcriptase activity was measured, as described in Figure 2.
Figure 5 Replication of SIV Vpx mutant molecular clones in
primary macaques PBMCs and macrophages. A) Wild type and
Vpx mutant SIVs were used to infect macaque PBMCs, and reverse
transcriptase activity measured, as described in Figure 2, or B) M-
CSF-stimulated macaque monocyte-derived macrophages, and SIV
p27 antigen was measured.
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DCAF1, we analyzed the SIV Vpx mutants for their abil-
ity to bind DCAF1 (Figure 7) [18-21]. For this purpose,
a FLAG epitope tagged version wild type SIV Vpx and
each mutant was expressed in 293T cells. Interactions
with endogenous DCAF1 were analyzed by immunoblot
with a DCAF1 monoclonal antibody using the anti-
FLAG immunoprecipitates.(top panel). In contrast to
wild type Vpx and the SIV-X(102) mutant, the SIV-X(Y-
A) mutant did not bind to DCAF1, suggesting that Vpx
interactions with factors in addition to DCAF1 may be
important for the ability of Vpx to promote reverse
transcription in these cells.
Since recent studies demonstrated that SAMHD1 is a
cellular restriction factor for HIVs and SIVs in myeloid
cells, whose stability is regulated by DCAF1 and Vpx
[22,23], we assessed the stability of FLAG-tagged
SAMHD1 in the presence of wild type and mutant SIV
Vpx proteins (Figure 8). Co-expression of increasing
amounts of wild type Vpx resulted in 51-56% decreased
levels of SAMHD1 in 293T cells 72 hrs after transfec-
tion (Figure 8, top panel). Co-expression of increasing
amounts of SIV-X(102) mutants resulted in 9-28%
decreased levels of SAMHD1 (Figure 8, bottom panel),
which was significantly different from the results seen
with wild type Vpx, (p < 0.01). Co-expression of increas-
ing amounts of SIV- X(Y-A) had little if any effect on
levels of SamHD1 (Figure 8, middle panel), which was
also significantly different from the results seen with
Figure 6 Synthesis and integration of SIV DNA in primary human macrophages. Wild type and Vpx mutant SIVs were pseudotyped with
VSV-G and used to infect M-CSF-stimulated human monocyte-derived macrophages. After 24 or 48 hrs, total cellular DNA was harvested and
subjected to PCR reactions for A) early or B) late reverse transcription products, or C) levels of integrated viral DNA, performed in triplicate
assays. Levels of viral DNAs are relative to the average obtained with wild type SIVmne at each time point. The bars in each set of assays
indicate standard deviations of assays.
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wild type Vpx (p < 0.01). The effects on SAMHD1 stabi-
lity of SIV-X(102) and SIV-X(Y-A) were not significantly
different (p = .055).
Replication of SIVmne Vpx mutants in pigtail macaques
In order to assess the role of Vpx in vivo, wild-type
SIVmne027 and the three Vpx mutant SIVmne viruses
were used to infect juvenile pigtail macaque monkeys by
the intra-rectal route of inoculation. For this purpose
two animals per virus were infected with 10,000 TCID50
units of each virus. The experimental design is shown in
Figure 9A. One animal in each group was sacrificed at
21 days post infection and the second animal on day 42.
Blood was obtained at 0, 3, 7, 10, 14, 21, 28, 35, and 42
days after inoculation and used for virus load measure-
ments (Figure 6B), sequence analysis, and CD4 assays.
At necropsy, tissues were obtained from the rectum,
colon, cecum, ileoceccal junction, ileum, jejunum,
mesenteric lymph node, spleen, and a peripheral lymph
node.
CD4 levels were depressed compared to baseline
values at 10 days post infection in both wild-type
SIVmne027 infected monkeys (by 9.6% and 60%,
respectively, Table 1). In contrast all six macaques
infected with the Vpx mutant SIVs showed no reduction
in CD4 counts at 10 days post infection (CD4 increased
by 3.1-79%, mean 31%, t < 0.03 compared to wild-type
animals). Plasma virus load levels from SIVmne027
infected macaques reached peak values of 2.0 and 2.3 ×
108 copies/ml at 7 and 10 days after inoculation, respec-
tively (Figure 8, Table 1). In contrast, substantially lower
peak viral loads were seen in animals infected with the
mutant Vpx SIVs: SIVΔVpx infected macaques = < 50
and 3.0 × 106 copies/ml; SIV-X(y-a) infected macaques
= 0.2 × 106 and 4.4 × 106 copies/ml; and SIV-X(102)
infected macaques = < 50 and 0.3 × 106 copies/ml. To
determine whether the levels of plasma viremia observed
in the Vpx mutants resulted from reversion of the intro-
duced mutations, sequence analyses were performed.
Viral RNA was isolated from day 21 and 42 plasma; the
vpx region was amplified by RT PCR, cloned into a plas-
mid vector, and individual clones were sequenced (data
not shown). No clones were obtained from the plasma
of both SIV-X(102) infected animals and the SIVΔVpx
infected animal with undetectable levels of virus. Of the
analyzed clones, neither SIVΔVpx nor SIV-X(y-a)
showed reversions to wild-type sequence, indicating that
the observed levels of replication of the Vpx mutants
were not due to a reversion to wild-type sequences.
Only one mutation was observed- a conserved mutation
of A71V in the day 21 SIV-X(y-a) infected animal.
Pathology of SIVmne Vpx mutant infections
To identify and type the SIV-expressing cells in lymph
nodes and the gastrointestinal tract of the SIVmne027
infected animals, triple-label confocal microscopy using
SIV-specific ISH (green), and immunohistochemistry for
CD3+ T cells (red) and HAM56+ macrophages (blue)
was performed (Figure 10). Quantification of SIV-
infected cells showed that greater than 98% of the SIV +
cells were T-cells. Virus was not found in dendritic cells.
To characterize the dissemination of the Vpx mutant
viruses ISH for SIV was performed on the GI tract [gut-
associated lymphoid tissue (GALT) and lamina propria
(LP)], spleen, and mesenteric and peripheral nodes from
all infected macaques. SIV positive cells were detected
in all tissues of the wild-type SIVmne027 infected ani-
mal (Figure 10, Table 1). SIV positive cells were
detected in a peripheral node of both of the SIVΔVpx
infected macaques; however, virus was only detected in
other tissues in the SIVΔVpx macaque (27616) exhibit-
ing the detectable virus load. In this animal, virus was
observed in all tissues but the ileum. SIV positive cells
were detected only sporadically in the SIV-X(y-a)
infected animals. RNA was found in the GALT of the
ileocecal junction of both SIV-X(y-a) infected macaques,
in the GALT in the ileum of macaque 27618, and the
Figure 7 Interaction of SIV Vpx and X-102 with DCAF1. FLAG-
tagged wild type and mutant SIV Vpx expression clones were
transfected into 293 T cells, which were treated with 5 μM MG-132
at 24 h post-transfection. After 48 hrs post-transfection cell lysates
were immunoprecipitated with anti-FLAG antibody, and analyzed
on SDS-PAGE and immunoblot with anti-DCAF1 antibody (top
panel). Total cell lysates were analyzed by SDS-PAGE and
immunoblot with anti-DCAF1 and anti-FLAG (bottom panels).
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spleen and peripheral node of the other macaque (Table
1). Otherwise, tissues from SIV-X(y-a) infected maca-
ques were negative by ISH for SIV RNA. The tissues
from SIV-X(102) infected macaques did not contain any
SIV positive cells by ISH assay.
Discussion
The current studies confirmed and extended previous
findings on the role of Vpx in SIV infection in vitro and
dissemination in vivo [9,11,18,19,26]. Three SIV vpx
mutants were examined in the current study (Figure 1).
The unique positioning of vpx within the SIV genome
allowed the mutagenesis without disrupting the ORFs of
other viral genes. One SIV mutant eliminated Vpx
expression (SIVΔVpx); the second mutant truncated
Vpx and removed the C-terminal proline-rich domain
(SIV-X102); and the third mutant contained a substitu-
tion of tyrosines 66, 69, and 71 with alanines [SIV-X(y-
a)]. These three mutants were previously shown in HIV-
2 to produce viruses with defects in replication in
quiescent lymphocytes and MDMs [10,11]. The viruses
were found to be defective in PIC nuclear import in
quiescent lymphoid cells in culture. Moreover, the C-
terminal truncation and tyrosine mutant also disrupted
nuclear targeting of GFP-Vpx fusion proteins [10-12].
One caveat is that we cannot exclude the possibility that
the C-terminal truncation and tyrosine mutations in the
context of HIV-2 Vpx may have affected Vpx packaging
into virus particles.
Not surprisingly, the SIV vpx mutants produced phe-
notypes similar to their HIV-2 counterparts. Each
mutant was capable of generating high levels of virus
equivalent to that of wild type SIV in proliferating
CEMx174 cells and primary macaque PBMCs (Figures 3
and 5). The wild type SIVmne027 virus replicated to
high levels in both human and macaque MDMs in cul-
ture, whereas all of the SIV vpx mutants were defective
for replication in macrophages (Figures 4 and 5). Con-
sistent with recent findings for a role of SIV Vpx in
reverse transcription in macrophages, PCR analyses
Figure 8 Degradation of SAMHD1 by SIV Vpx and X-102. Increasing amounts of FLAG-tagged wild type and mutant SIV Vpx expression
clones were co-transfected with FLAG-tagged SAMHD1 expression clones into 293T cells. After 72 hrs cell lysates were analyzed on PAGE-SDS
and immunoblotted with anti-Flag and anti-Actin antibodies. Positions of SAMHD1, Actin, and Vpx in the blots are indicated. Densitometry
values (normalized to levels of actin), relative to SAMHD1 in the absence of Vpx, are shown below each blot.
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demonstrated that early reverse transcriptase products
were decreased in macrophages infected with the SIV
vpx mutant viruses compared to wild type SIVmne027
(Figure 6). As expected, and consistent with the reduc-
tions in early reverse transcription products, the levels
of late reverse transcriptase products and integrated
DNA, examined 24 and 48 hrs after infection, were also
more profoundly decreased in the vpx mutant SIV infec-
tions compared to wild type SIVmne027 infected cells
(Figure 6) [18,19]. Furthermore, reductions in reverse
transcription by the Vpx mutants did not correlate with
binding to DCAF1. It is notable however, that the cur-
rent findings do not exclude additional effects of Vpx in
macrophages in regulating steps before the initiation, or
after the completion of reverse transcription, such as
virus uncoating and preintegration complex nuclear
import.
The in vivo studies with these SIV clones were per-
formed in an established pigtail macaque infection
model [30,31]. The number of experimental animals was
limited by funding considerations to two macaques per
virus. Unfortunately, this did not permit statistical ana-
lyses. Intra-rectal inoculation was chosen for the route
of infection as it requires virus transport across a muco-
sal barrier, similar to that occurring during HIV infec-
tion in humans. This route of infection of macaques has
been shown to reproducibly yield rapid virus dissemina-
tion to lymphoid tissues [26,32]. As expected, both wild
type SIVmne027 infected macaques exhibited high levels
of plasma virus load 7-10 days after infection. However,
despite the consistency of the model, variation was seen
in plasma virus loads among macaques infected with
SIV vpx mutant viruses. All vpx mutant SIV infected
animals had substantially lower peak virus loads than
the SIVmne027 infected animals. Two of the six maca-
ques infected with vpx mutant viruses failed to produce
detectable virus loads in plasma. Another two produced
peak levels of less than or equal to 300,000 copies/ml,
which represented a > 460,000-fold reduction in virus
load versus the SIVmne027 infected animals. The final
two macaques infected with vpx mutant viruses had at
least a 45-fold lower peak level of viremia compared to
the SIVmne027 infected macaques. The overall trend of
the vpx mutant viruses is consistent with previous find-
ings that Vpx is required for dissemination in vivo [26].
An earlier study of SIVmac demonstrated progression
to AIDS in the absence of a gene for vpx [33]. In this
study, macaques were infected intravenously, unlike our
study in which mucosal infection was utilized. It is nota-
ble that in the previous study, the number of infected
lymphocytes was lower in animals infected with mutant
compared to wild type SIV at all time points. Moreover,
fewer positive cells were detected at 2 weeks by in situ
hybridization in the lymph nodes in animals infected
with mutant compared to wild type SIV. In addition, the
time to death was longer in the animals infected with
mutant compared to wild type SIV.
Our in situ hybridization studies demonstrated SIV
RNA expressing cells in both the mesenteric nodes of
wild type SIVmne027 infected macaques and all other
tissues examined, including rectal, intestinal epithelium,
spleen, and peripheral node. These studies also con-
firmed previous observations that the predominant
infected cell type is the intraepithelial lymphocyte rather
than macrophages or dendritic cells [26,34]. In contrast,
SIV RNA was found rarely in tissues and not identified
in the rectum in five of the six macaques infected with
SIV vpx mutant viruses. These findings confirm the role
of Vpx in dissemination of virus, and extend findings
obtained with SIVsmm pbj to a second virus,
SIVmne027 [26]. More importantly, these findings
demonstrate that specific mutations within Vpx that dis-
rupt replication in vitro also inhibit virus dissemination
in vivo. It is likely that these functions of Vpx are
important for infection of resting T cells in the rectum
Figure 9 Effect of Vpx mutations on SIV replication in pigtail
macaques. A) The design of the macaque infection shows that
animals were inoculated by intra-rectal challenge, and one of two
animals were sacrificed at 21 days after infection (✝), and the
second animal in each group at 42 days after infection. Time points
at which blood samples were obtained are also indicated. B) Plasma
levels of SIV RNA (copies/ml) are indicated on a log scale for each
of the 8 animals. The limit of detection in this assay was 50 copies/
ml.
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[35]. Perhaps nucleotide triphosphate levels for efficient
reverse transcription are limiting in quiescent T cells,
similar to that in myeloid cells, which could explain the
requirement for Vpx for efficient SIV infection [36,37]
One notable difference of the current results com-
pared with those reported with SIVsmm pbj infection
report is that in the current study Vpx also appears to
be important for amplification of local infection prior to
distant dissemination [26]. This was demonstrated by
the failure to identify SIV RNA in the rectal crypts and
lamina propria within five of the six Vpx mutant SIV-
infected animals. It is possible that differences in experi-
mental design contributed to this distinct finding. A
striking difference between these studies was the use of
acutely lethal strain of SIVsmm pbj in the previous
study, and a less rapidly lethal AIDS-inducing strain of
SIVmne in the current study. Other technical differences
between these studies may also account for this result,
possibly related to the dose of virus used in the inocu-
lums (10,000 TCID50 in the current study compared to
2,000 TCID50 previously), or the fact that in the current
study tissues were examined at 21 and 42 days after
infection, whereas in the previous study, in situ hybridi-
zation was performed at earlier time points. Despite
these caveats, both studies demonstrate an important
role for Vpx in establishing SIV infection in vivo. More-
over, the current study demonstrates a correlation of
the ability of Vpx to overcome the restriction to virus
replication in monocyte-derived macrophages in vitro
and successful establishment of virus infection in vivo.
Conclusions
The current study utilized SIVmne027 with a mutation
that prevents Vpx expression, or mutations in the con-
served tyrosines or the C-terminal proline-rich domain
that inhibit the nuclear import of Vpx. All three mutant
forms of Vpx attenuated SIV replication in monocyte-
derived macrophages, reduced the synthesis and integra-
tion of viral DNA, and were impaired in the ability to
promote SAMHD1 degradation. Moreover, all the Vpx
mutants were defective in promoting efficient replication
of SIVmne in pigtail macaques, and were associated
with decreased viral RNA in gut-associated lymphoid
tissue and lamina propria, spleen, and mesenteric nodes.
These findings demonstrate that the ability of Vpx to
overcome restrictions in culture is also likely to be
important for establishing infection in vivo.
Methods
Viruses
The infectious, pathogenic clone, SIVmne027 (SIVmne),
was obtained from the lymph node of a macaque with a
declining CD4 cell count and early signs of AIDS [29].
Mutations in vpx were constructed by splice overlap
Table 1 In situ RNA hybridization (ISH) results from tissues of SIVmne infected pigtail macaques
SIVmne virus Vpx-WT ΔVpx Vpx: y-a Vpx: 102
Macaque No. 27617 27614 27616 27613 27618 27615 28487 28486
Virus Loads
Peak VL (x 10-6 copies/ml) 230 200 3.1 0 0.2 4.4 0.3 0
VL at Necropsy (x 10-6 copies/ml) 93.5 19.9 3.1 0 0.2 1.5 0 0
CD4 counts
day 0 1057 2053 1277 2179 1823 1511 819 1176
day 10 955 808 2284 2615 2302 1802 1139 1212
day 21 1109 2740 1531 2818 1954 1701 460 869
day 42 1280 3547 1189 864
ISH in Tissue
Rectum + (LP, GALT) ND + 0 0 0 0 0
Colon + (LP, GALT) ND + (GALT) 0 0 0 0 0
Cecum + (LP, GALT) ND + (GALT) 0 0 0 0 0
Ileoceccal Junction + (LP, GALT) ND + (GALT/LP) 0 + (GALT) + (GALT) 0 0
Ileum + ND 0 0 + (GALT) 0 0 0
Jejunum + (LP, GALT) ND + (GALT) 0 0 0 0 0
Mesenteric Node ND + + 0 0 0 0 0
Spleen + ND + (and LN) 0 0 + 0 0
Peripheral Node + ND + + 0 + 0 0
ISH was scored as +, SIV RNA expressing cells present; 0, SIV RNA expressing cell not present; ND, not done
Abbreviations: GALT, gut associated lymphoid tissue; LN, lymph node; LP, lamina propria;
Belshan et al. Retrovirology 2012, 9:32
http://www.retrovirology.com/content/9/1/32
Page 9 of 13
PCR mutagenesis, engineered into the SIVmne027 mole-
cular clone, and confirmed by restriction enzyme digests
and sequence analysis. For in vitro replication assays,
molecular clones were transfected into 293T cells using
TransIT-LT (Mirus Bio), virus harvested 48-72 hrs later,
and quantified by SIV p27 antigen ELISA (ZeptoMetrix).
For PCR assays, SIV molecular clones were co-trans-
fected with a VSV-G expression clone, and quantified by
JC53 assays [38,39]. For in vivo replication studies, SIV
stocks were grown in CEMx174 cells after infection
with filtered SIV virus stocks generated from 293T cells.
Supernatants were harvested 7-10 days post-inoculation,
passed through 0.45 mM syringe filters, and stored at
-80°C until needed. Infectious virus was quantified using
the sMAGI assay [40].
In vitro replication assays
CEM and CEM × 174 cells were grown in RPMI-1640
with 10% fetal calf serum, 4 mM L-glutamine, 1 mM
sodium pyruvate, and 100 μg/ml penicillin-streptomycin.
Human peripheral blood monocytes were obtained by
leukopheresis from HIV-1 and hepatitis seronegative
donors and purified by counter-current centrifugal elu-
triation to > 99% purity as assessed by immunolabeling
with anti-CD68 [41]. Monocytes were plated for 7-14
days in RPMI-1640 supplemented with 500 U/ml M-
CSF, and the supplements used above for CEM × 174
cells. Pigtailed macaque PBMCs were separated from
whole blood by density centrifugation with 95% LSM
(MP Biomedicals, Solon, OH) and stimulated with 2 μg/
ml of PHA (Sigma-Aldrich, St. Louis, MO) and 10 ng/
ml of human interleukin-2 (IL-2; R&D Systems, Minnea-
polis, MN) in RPMI 1640, supplemented with 10% heat-
inactivated FCS, 4 mM glutamine, 100 U/ml of penicil-
lin, and 100 μg/ml streptomycin for 3 days and then
washed and maintained in complete RPMI 1640 supple-
mented with IL-2. Reverse transcriptase assays were per-
formed as previously described [41].
Pig-tail monocytes were isolated by plastic adherence
from pig-tailed macaque PBMCs and differentiated into
macrophages (MDMs) as previously described [30].
MDMs were infected at a multiplicity of infection (MOI)
of 0.01. Viral replication was monitored by measuring
SIV p27 in culture supernatants by ELISA (Advanced
Bioscience Laboratories, Inc., Kensington, MD).
For real time PCR assays, monocyte-derived macro-
phages were infected with 300 or 200 ng (p27) of virus,
respectively, pretreated with TURBO DNase (Ambion,
Austin, TX). DNA was harvested 24 and 48 hrs after
infection with the DNeasy tissue kit (Qiagen). For early
reverse transcriptase products, the following primers in
U5 were used: 5’GAGGCTGGCAGATTGAGCCCTG
and 5’GGTCCTAACAGACCAGGGTCT. For late
reverse transcriptase products, the following primers in
gag were used: 5’TCCGTCTTGTCAGGGAAGAAAGCA
and 5’AGCCTGTTGGCACTAATGGAGCTA. Alu-inte-
gration assays were performed by real time PCR as pre-
viously described, except that the primer in the 2nd
round PCR complementary to SIVmne LTR was
5’GGTCCTAACAGACCAGGGTCT [13]. For total viral
DNA assays, AZT treatment was performed to measure
background levels, which were subtracted from experi-
mental values. For Alu-integration assays, a control with-
out Alu primers was performed, and background levels
were subtracted from experimental values.
Packaging
Plasmids encoding FLAG-tagged SIV Vpx mutants and
Wt Vpx (3 μg), in conjunction with proviral plasmids
encoding SIVmne lacking Vpx expression (3 μg), were
Figure 10 In situ hybridization results of mesenteric node from
a SIV infected pigtail macaque. A) Mesenteric lymph node from a
macaque 21 days after infection with wild type SIVmne contains SIV
viral RNA expressing cells (dark blue). Magnification, 20×. B)
Confocal microscopy (3 channel overlay) from a day 21 mesenteric
lymph node from a wild type SIVmne infected macaque: ISH for SIV
viral RNA was performed with a fluorescent tyramide signal
amplification technique (green) and was combined with fluorescent
IHC detection of HAM56-positive macrophages (blue) and CD3
positive lymphocytes (red). Magnification, 63×
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transiently co-transfected into 293 T cells using Tran-
sIT-LT1 Reagent (Mirus Bio). MG-132 (5 μM) was
added to all cells 24 h post-transfection. After 48 hours,
supernatants were collected and filtered through 0.45
micron filters while the cells were collected and lysed in
Laemmli sample buffer. Virions were ultracentrifuged
on a 20% sucrose cushion for 1 h, at 45,000 rpm, and in
an SW55 Beckman rotor. Virion samples were resolved
on PAGE-SDS, transferred to a PVDF, and blotted with
Flag mAb (Sigma M2) for Vpx and HIV-1 Gag serum
for Capsid.
Immunoprecipitation
Plasmids encoding FLAG-tagged SIV Vpx mutants and
Wt Vpx (4 μg) were transiently transfected into 293 T
cells TransIT-LT1 Reagent (Mirus Bio). MG-132 (5 μM)
was added to all cells 24 h post-transfection. After 48 h,
cells were lysed using Triton X-100 detergent-containing
buffer (10 mM Tris-HCl pH7.5, 150 mM NaCl, 1% Tri-
ton X-100, and complete protease inhibitor (Roche)).
After clarification, 5% of total cell lysate was saved for
Vpx and DCAF1 blotting, the rest of the lysate was used
for Vpx pulldown with mouse anti-FLAG antibody
(Sigma) and protein A/G PLUS-agarose (Santa Cruz
Biotechnology). Agarose beads were washed 5 times
with 1XPBS. Vpx was eluted from agarose with SDS-
PAGE sample buffer, boiled, and resolved using 8%
SDS-PAGE. Vpx was detected using mouse anti-FLAG
(Sigma) whereas DCAF1 was detected using rabbit anti-
VprBP (ProteinTech Group) and HRP-linked anti-
mouse (Sigma) and anti-rabbit (Thermo Scientific) sec-
ondary antibodies. Bands were developed with Super-
Signal West Femto Substrate (Thermo Scientific) and
developed using Bio-Rad ChemiDoc XRS+ (Bio-Rad).
Increasing amounts of plasmids encoding FLAG-
tagged SIV Vpx mutants (0.0 μg, 0.4 μg, 0.8 μg, and 1.2
μg for Wt Vpx and Y-A Vpx, and 0.0 μg, 1.2 μg, 1.6 μg,
and 2.0 μg for 102 Vpx) and FLAG-tagged human
SAMHD1 (0.1 μg) were transiently transfected into 293
T cells with TransIT-LT1 Reagent (Mirus Bio). After 72
hrs, whole-cell extracts were prepared with Laemmli
sample buffer and samples were analyzed on PAGE-
SDS. PVDF-bound proteins were incubated with anti-
Flag (Sigma M2) and anti-Actin-HRP (Santa Cruz Bio-
technology) antibody. The intensity of bands was deter-
mined with image analysis software (Bio-Rad Image Lab
3.0). Densitometry values were normalized to actin and
set relative to SAMHD1 in the absence of Vpx. A 2-
tailed t-test was used to assess the different results.
In vivo infection assays
Juvenile pig-tailed macaques (M. nemestrina), 2 yrs old
and negative for SIV and simian type D retrovirus, were
inoculated intrarectally with equal amounts (104 tissue
culture infectious doses, TCID50, as determined by a
MAGI assay) of SIVMne027 [40]. From each inoculated
macaque serial samples of peripheral blood and plasma
were obtained at days 0, 3, 7, 10, and 14, and then
weekly to monitor CD4+ T lymphocyte levels, and viral
loads. All animals were maintained and cared for in
accordance with the guidelines of the AAALAC and the
Animal Care and Use Committee of the Southwest
National Primate Research Center at The Texas Biome-
dical Research Institute. Lymphocyte phenotyping assays
were performed by flow cytometry with antibodies to
CD3 (clone SP34.2), CD4 (clone L200), and CD8 (clone
RPA-T8) (BD Biosciences, San Jose, CA). SIV RNA
plasma virus load assays were run by a nucleic acid
based amplification assay (Advances Biosciences).
In situ hybridization (ISH) assays
Formalin-fixed, paraffin-embedded tissues were assayed for
SIV expression by an ISH assay [42]. Sections from the
widest part of the lymph node or GI tract were used for
staining. Sections were hybridized overnight with a full-
length sense or antisense SIVmac239 digoxigenin-UTP
labeled riboprobe, followed by sheep anti-digoxigenin-alka-
line phosphatase (Roche Molecular) and nitroblue tetrazo-
lium-5-bromo-4-chloro-3-indoyl-b-D-galactopyranoside
(NBT/BCIP). The slides were counter stained with nuclear
fast red and photographed with a Zeiss Axiophot micro-
scope. The number of SIV + cells observed in different sec-
tions was very consistent from slide to slide. For confocal
microscopy, tissue sections, hybridized as described above,
were incubated with sheep anti-digoxigenin-horseradish
peroxidase, and detected with a fluorescein tyramide signal
amplification technique [42]. The sections were stained
with HAM56, anti-human macrophage antibody (DAKO)
followed by a biotinylated secondary and streptavidin-
Alexa633 (Molecular Probes). The samples were then incu-
bated with rabbit anti-human CD3 (DAKO), followed by
goat anti-rabbit IgG-Alexa594 (Molecular Probes) and
cover slipped with Vectashield Hardset (Vector Labora-
tories). Triple stained sections were photographed with a
Leica confocal scanning microscope.
Additional material
Additional file 1: Figure S1 Expression of SIV Vpx mutants. SIV
molecular clones lacking Vpx expression were complemented in trans
with indicated Vpx mutants and Vpx WT by transient transfection of 293T
cells. MG132 was added 24 h post-transfection. Cells were lysed in
Laemmli sample buffer at 48 h and Vpx expression were analyzed by
immunoblot using FLAG mAb. (PDF 175 kb).
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